+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intravenous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 297 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5913388
Description Jump to:
The global intravenous immunoglobulin market is on a robust growth trajectory, with projections indicating that it will reach a market value of US$ 14 Billion in 2024 and is expected to accumulate a market value of US$ 24 Billion by 2031. This significant expansion can be attributed to various factors, including the growing prevalence of immunodeficiency diseases, the adoption of intravenous immunoglobulin (IVIG) treatments, and the rising use of off-label indications.

Key Factors Driving Market Growth

  • Rising Incidence of Immunodeficiency Diseases: The increasing number of patients with immunodeficiency disorders is a primary driver for the development and demand for IVIG preparations. These therapies have become a vital treatment option for individuals with immunodeficiency conditions.
  • Chronic Inflammatory Diseases: The global IVIG market is expanding rapidly due to the rising number of patients with chronic inflammatory diseases and conditions such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). This expansion is further fueled by substantial investments in the healthcare sector.
  • COVID-19 Pandemic: The ongoing COVID-19 pandemic has emphasized the importance of immunoglobulin therapies, especially for individuals with primary and secondary immunodeficiency disorders. Immunocompromised individuals are at a higher risk of contracting COVID-19, leading to an increased demand for IVIG therapy during the pandemic.
  • Availability of Various Therapies: The availability of IVIG therapy has offered new treatment options for patients with various health conditions, including mental and neurological disorders. The therapy has also shown promise in addressing complications associated with COVID-19, such as MIS-C.
  • Growing Awareness of Primary Immune Deficiencies (PIDs): There are over 50 different PIDs affecting millions of patients worldwide. The growing awareness of these conditions is expected to drive the demand for immunoglobulin therapies in the coming years.

Challenges Ahead

  • Lack of Awareness: A significant hindrance to market growth is the lack of awareness among patients about the benefits of IVIG therapy, leading to delayed or inadequate treatment.
  • High Treatment Costs: IVIG therapy can be expensive, with costs ranging from USD 10,000 to USD 30,000 annually depending on the severity of the illness. The high costs act as a barrier to market expansion.

Regional Market Dynamics

  • North America: The North American market is witnessing growth due to increasing healthcare expenditure, rising awareness among clinicians, and the presence of established healthcare infrastructure. Autoimmune diseases are on the rise, further driving the demand for IVIG therapy.
  • Asia Pacific: The Asia Pacific region is expected to exhibit significant growth, driven by increasing awareness of immunoglobulin-based therapies, a growing geriatric population, and improving healthcare facilities. Rising incidences of immune disorders are also contributing to market expansion.

Key Players in the Market

Several companies are actively contributing to the growth of the intravenous immunoglobulin market, including Biotest AG, Baxter International Inc., Octopharma AG, LFB Biotechnologies, Grifols SA, Argenx, CSL Behring, China Biologics Products Inc., Kedrian Biopharma, BDI Pharma Inc., and Pfizer Inc.

Intravenous Immunoglobulin Industry Research by Category

By Type

  • IgG
  • IgM
  • IgA
  • IgE
  • IgD

By Application

  • Hypogammaglobulinemia
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Immunodeficiency Diseases
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • Idiopathic Thrombocytopenic Purpura
  • Inflammatory Myopathies
  • Specific Antibody Deficiency
  • Guillain-Barre Syndrome
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Others

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Intravenous Immunoglobulin Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Intravenous Immunoglobulin Market Outlook, 2018 - 2031
3.1. Global Intravenous Immunoglobulin Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. IgG
3.1.1.2. IgM
3.1.1.3. IgA
3.1.1.4. IgE
3.1.1.5. IgD
3.2. Global Intravenous Immunoglobulin Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hypogammaglobulinemia
3.2.1.2. Chronic Inflammatory Demyelinating Polyneuropathy
3.2.1.3. Immunodeficiency Diseases
3.2.1.4. Myasthenia Gravis
3.2.1.5. Multifocal Motor Neuropathy
3.2.1.6. Idiopathic Thrombocytopenic Purpura
3.2.1.7. Inflammatory Myopathies
3.2.1.8. Specific Antibody Deficiency
3.2.1.9. Guillain-Barre Syndrome
3.2.1.10. Others
3.3. Global Intravenous Immunoglobulin Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospital Pharmacy
3.3.1.2. Retail Pharmacy
3.3.1.3. Others
3.4. Global Intravenous Immunoglobulin Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Hospitals
3.4.1.2. Specialty Clinics
3.4.1.3. Others
3.5. Global Intravenous Immunoglobulin Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Intravenous Immunoglobulin Market Outlook, 2018 - 2031
4.1. North America Intravenous Immunoglobulin Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. IgG
4.1.1.2. IgM
4.1.1.3. IgA
4.1.1.4. IgE
4.1.1.5. IgD
4.2. North America Intravenous Immunoglobulin Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hypogammaglobulinemia
4.2.1.2. Chronic Inflammatory Demyelinating Polyneuropathy
4.2.1.3. Immunodeficiency Diseases
4.2.1.4. Myasthenia Gravis
4.2.1.5. Multifocal Motor Neuropathy
4.2.1.6. Idiopathic Thrombocytopenic Purpura
4.2.1.7. Inflammatory Myopathies
4.2.1.8. Specific Antibody Deficiency
4.2.1.9. Guillain-Barre Syndrome
4.2.1.10. Others
4.3. North America Intravenous Immunoglobulin Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospital Pharmacy
4.3.1.2. Retail Pharmacy
4.3.1.3. Others
4.4. North America Intravenous Immunoglobulin Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Hospitals
4.4.1.2. Specialty Clinics
4.4.1.3. Others
4.5. North America Intravenous Immunoglobulin Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Intravenous Immunoglobulin Market Outlook, 2018 - 2031
5.1. Europe Intravenous Immunoglobulin Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. IgG
5.1.1.2. IgM
5.1.1.3. IgA
5.1.1.4. IgE
5.1.1.5. IgD
5.2. Europe Intravenous Immunoglobulin Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hypogammaglobulinemia
5.2.1.2. Chronic Inflammatory Demyelinating Polyneuropathy
5.2.1.3. Immunodeficiency Diseases
5.2.1.4. Myasthenia Gravis
5.2.1.5. Multifocal Motor Neuropathy
5.2.1.6. Idiopathic Thrombocytopenic Purpura
5.2.1.7. Inflammatory Myopathies
5.2.1.8. Specific Antibody Deficiency
5.2.1.9. Guillain-Barre Syndrome
5.2.1.10. Others
5.3. Europe Intravenous Immunoglobulin Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospital Pharmacy
5.3.1.2. Retail Pharmacy
5.3.1.3. Others
5.4. Europe Intravenous Immunoglobulin Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Specialty Clinics
5.4.1.3. Others
5.5. Europe Intravenous Immunoglobulin Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
5.5.1.2. Germany Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.3. Germany Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.4. Germany Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.5. U.K. Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.8. U.K. Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.9. France Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
5.5.1.10. France Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.11. France Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.12. France Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.13. Italy Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
5.5.1.14. Italy Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.16. Italy Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.17. Turkey Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
5.5.1.18. Turkey Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.19. Turkey Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.20. Turkey Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.21. Russia Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
5.5.1.22. Russia Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.24. Russia Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
5.5.1.25. Rest of Europe Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
5.5.1.26. Rest of Europe Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
5.5.1.27. Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1.28. Rest of Europe Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Intravenous Immunoglobulin Market Outlook, 2018 - 2031
6.1. Asia Pacific Intravenous Immunoglobulin Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. IgG
6.1.1.2. IgM
6.1.1.3. IgA
6.1.1.4. IgE
6.1.1.5. IgD
6.2. Asia Pacific Intravenous Immunoglobulin Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hypogammaglobulinemia
6.2.1.2. Chronic Inflammatory Demyelinating Polyneuropathy
6.2.1.3. Immunodeficiency Diseases
6.2.1.4. Myasthenia Gravis
6.2.1.5. Multifocal Motor Neuropathy
6.2.1.6. Idiopathic Thrombocytopenic Purpura
6.2.1.7. Inflammatory Myopathies
6.2.1.8. Specific Antibody Deficiency
6.2.1.9. Guillain-Barre Syndrome
6.2.1.10. Others
6.3. Asia Pacific Intravenous Immunoglobulin Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospital Pharmacy
6.3.1.2. Retail Pharmacy
6.3.1.3. Others
6.4. Asia Pacific Intravenous Immunoglobulin Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Specialty Clinics
6.4.1.3. Others
6.5. Asia Pacific Intravenous Immunoglobulin Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
6.5.1.2. China Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.3. China Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.4. China Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.8. Japan Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.9. South Korea Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
6.5.1.10. South Korea Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.11. South Korea Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.12. South Korea Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.13. India Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
6.5.1.14. India Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.15. India Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.16. India Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.17. Southeast Asia Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
6.5.1.18. Southeast Asia Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.19. Southeast Asia Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.20. Southeast Asia Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Intravenous Immunoglobulin Market Outlook, 2018 - 2031
7.1. Latin America Intravenous Immunoglobulin Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. IgG
7.1.1.2. IgM
7.1.1.3. IgA
7.1.1.4. IgE
7.1.1.5. IgD
7.2. Latin America Intravenous Immunoglobulin Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.2.1.1. Hypogammaglobulinemia
7.2.1.2. Chronic Inflammatory Demyelinating Polyneuropathy
7.2.1.3. Immunodeficiency Diseases
7.2.1.4. Myasthenia Gravis
7.2.1.5. Multifocal Motor Neuropathy
7.2.1.6. Idiopathic Thrombocytopenic Purpura
7.2.1.7. Inflammatory Myopathies
7.2.1.8. Specific Antibody Deficiency
7.2.1.9. Guillain-Barre Syndrome
7.2.1.10. Others
7.3. Latin America Intravenous Immunoglobulin Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospital Pharmacy
7.3.1.2. Retail Pharmacy
7.3.1.3. Others
7.4. Latin America Intravenous Immunoglobulin Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Specialty Clinics
7.4.1.3. Others
7.5. Latin America Intravenous Immunoglobulin Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
7.5.1.2. Brazil Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.4. Brazil Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
7.5.1.5. Mexico Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
7.5.1.6. Mexico Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.8. Mexico Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
7.5.1.9. Argentina Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
7.5.1.10. Argentina Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
7.5.1.11. Argentina Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.12. Argentina Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
7.5.1.15. Rest of Latin America Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1.16. Rest of Latin America Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Intravenous Immunoglobulin Market Outlook, 2018 - 2031
8.1. Middle East & Africa Intravenous Immunoglobulin Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. IgG
8.1.1.2. IgM
8.1.1.3. IgA
8.1.1.4. IgE
8.1.1.5. IgD
8.2. Middle East & Africa Intravenous Immunoglobulin Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hypogammaglobulinemia
8.2.1.2. Chronic Inflammatory Demyelinating Polyneuropathy
8.2.1.3. Immunodeficiency Diseases
8.2.1.4. Myasthenia Gravis
8.2.1.5. Multifocal Motor Neuropathy
8.2.1.6. Idiopathic Thrombocytopenic Purpura
8.2.1.7. Inflammatory Myopathies
8.2.1.8. Specific Antibody Deficiency
8.2.1.9. Guillain-Barre Syndrome
8.2.1.10. Others
8.3. Middle East & Africa Intravenous Immunoglobulin Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospital Pharmacy
8.3.1.2. Retail Pharmacy
8.3.1.3. Others
8.4. Middle East & Africa Intravenous Immunoglobulin Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Specialty Clinics
8.4.1.3. Others
8.5. Middle East & Africa Intravenous Immunoglobulin Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.4. GCC Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
8.5.1.5. South Africa Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
8.5.1.6. South Africa Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
8.5.1.7. South Africa Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.8. South Africa Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
8.5.1.9. Egypt Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.12. Egypt Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
8.5.1.13. Nigeria Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
8.5.1.15. Nigeria Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.16. Nigeria Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Intravenous Immunoglobulin Market by Type, Value (US$ Bn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Intravenous Immunoglobulin Market by Application, Value (US$ Bn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Intravenous Immunoglobulin Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Intravenous Immunoglobulin Market by End User, Value (US$ Bn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. by Distribution Channel vs by Application Heatmap
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Biotest AG
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Baxter International Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Octapharma AG
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. LFB Biotechnologies
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Grifols SA
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. CSL Behring
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. China Biologics Products Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Kedrion Biopharma
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. BDI Pharma Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Pfizer Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Biotest AG
  • Baxter International Inc.
  • Octapharma AG
  • LFB Biotechnologies
  • Grifols SA
  • CSL Behring
  • China Biologics Products Inc.
  • Kedrion Biopharma
  • BDI Pharma Inc.
  • Pfizer Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Intravenous Immunoglobulin Market Report and Forecast 2023-2031 - Product Image

Global Intravenous Immunoglobulin Market Report and Forecast 2023-2031

  • Report
  • 140 Pages
  • Global
From
Intravenous Immunoglobulin Global Market Report 2024 - Product Image

Intravenous Immunoglobulin Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Immunoglobulin Market Analysis & Forecast 2024-2034: Market By Product; By Route of Administration; By Application; By End-user; and By Region - Product Image

Global Immunoglobulin Market Analysis & Forecast 2024-2034: Market By Product; By Route of Administration; By Application; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From
Intravenous Immunoglobulin (IVIg): Global Strategic Business Report - Product Image

Intravenous Immunoglobulin (IVIg): Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.